首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Reply: RE: a cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany,Italy, and Spain
Authors:Salvatore Gizzo  Marcos Ferrando  Monica Lispi  Claudio Ripellino  Nazarena Cataldo  Klaus Bühler
Institution:1. Department of Women and Children’s Health SDB, Policlinico Abano Terme, Padova, Italy;2. Department of Reproductive and Gynaecological Medicine, Instituto Valenciano de Infertilidad (IVI–RMA), Bilbao, Spain;3. Regional Medical Affairs Fertility, Merck Serono S.p.A., Rome, Italy, an affiliate of Merck KGaA, Darmstadt, Germany;4. Freelance HEOR Consultant, Quintiles IMS, Milan, Italy;5. Quintiles IMS, Milan, Italy;6. Centre for Gynaecology, Endocrinology, and Reproductive Medicine, Ulm and Stuttgart, Germany;7. Department of Gynaecology, Jena-University Hospital-Friedrich Schiller University, Jena, Germany
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号